To determine the seroprevalence of antibodies against dengue virus (DENV) and West Nile virus (WNV) in the human population of the Bolivian Chaco, we tested 256 inhabitants of two rural communities. The seroprevalence, confirmed by plaque reduction neutralization test, was 7.8% and 2.7% for DENV and WNV, respectively.

Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco / Bartoloni, A.; Remoli, M. E.; Farchi, F.; Zammarchi, L.; Fortuna, C.; Benedetti, E.; Ciufolini, M. G.; Macchioni, F.; Rojas, P.; Lara, Y.; Padilla, C.; Roselli, M.; Mantengoli, E.; Mantella, A.; Tolari, F.; Paredes, G. A.; Monasterio, J.; Valdarchi, C.; Venturi, G.; Rezza, G.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 91:1(2019), pp. 146-150. [10.1002/jmv.25283]

Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco

Rezza G.
Ultimo
2019-01-01

Abstract

To determine the seroprevalence of antibodies against dengue virus (DENV) and West Nile virus (WNV) in the human population of the Bolivian Chaco, we tested 256 inhabitants of two rural communities. The seroprevalence, confirmed by plaque reduction neutralization test, was 7.8% and 2.7% for DENV and WNV, respectively.
2019
Americas
Bolivia
dengue virus
flavivirus
Latin America
West Nile virus
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/157217
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact